期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
Efficacy and safety of thermobalancing therapy with Dr Allen’s Device for chronic low back pain:A randomised controlled trial
1
作者 Simon Allen Abid Rashid +4 位作者 Ariana Adjani Muhammad Akram Fahad Said Khan Rehan Sherwani Muhammad Talha Khalil 《World Journal of Orthopedics》 2023年第12期878-888,共11页
BACKGROUND Lumbar disc herniation and non-specific low back pain are common conditions that seriously affect patients’health-related quality of life(HRQoL).Although empirical evidence has demonstrated that novel Ther... BACKGROUND Lumbar disc herniation and non-specific low back pain are common conditions that seriously affect patients’health-related quality of life(HRQoL).Although empirical evidence has demonstrated that novel Thermobalancing therapy and Dr Allen’s Device can relieve chronic low back pain,there have been no randomised controlled trials for these indications.AIM To evaluate the efficacy of Dr Allen’s Device in lumbar disc herniation(LDH)and non-specific low back pain(NSLBP).METHODS A randomised clinical trial was conducted investigating 55 patients with chronic low back pain due to LDH(n=28)or NSLBP(n=27),out of which 15 were randomly assigned to the control group and 40 were assigned to the treatment group.The intervention was treatment with Dr Allen’s Device for 3 mo.Changes in HRQoL were assessed using the Numerical Pain Rating Scale and the Japanese Orthopedic Association Back Pain Questionnaire.RESULTS Thermobalancing therapy with Dr Allen’s Device showed a significant reduction in pain in the treatment group(P<0.001),with no recorded adverse effects.Both pain assessment scales showed a significant improvement in patients’perception of pain indicating improvement in HRQoL.CONCLUSION The out-of-hospital use of Thermobalancing therapy with Dr Allen’s Device for Low Back Treatment relieves chronic low back pain significantly and without adverse effects,improves the level of activity and HRQoL among patients with LDH and NSLBP.This study demonstrates the importance of this safe first-line therapy that can be used for effective at-home management of chronic low back pain. 展开更多
关键词 Chronic low back pain Lumbar disc herniation Non-specific low back pain Thermobalancing therapy Dr Allen’s Device Numerical pain rating scale
下载PDF
Effects of medicinal plants on Alzheimer's disease and memory deficits 被引量:7
2
作者 Muhammad Akram Allah Nawaz 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第4期660-670,共11页
Alzheimer's disease is an age-related neurodegenerative disorder characterized by memory deficits. Various studies have been carried out to find therapeutic approaches for Alzheimer's disease. However, the proper tr... Alzheimer's disease is an age-related neurodegenerative disorder characterized by memory deficits. Various studies have been carried out to find therapeutic approaches for Alzheimer's disease. However, the proper treatment option is still not available. There is no cure for Alzheimer's disease, but symptomatic treatment may improve the memory and other dementia related problems. Traditional medicine is practiced world- wide as memory enhancer since ancient times. Natural therapy including herbs and medicinal plants has been used in the treatment of memory deficits such as dementia, amnesia, as well as Alzheimer's disease since a long time. Medicinal plants have been used in different systems of medicine, particularly Unani system of medicines and exhibited their powerful roles in the management and cure of memory disorders. Most of herbs and plants have been chemically evaluated and their efficacy has also been proven in clinical trials. However, the underlying mechanisms of actions are still on the way. In this paper, we have reviewed the role of different medicinal plants that play an important role in the treatment of Alzheimer's disease and memory deficits using conventional herbal therapy. 展开更多
关键词 nerve regeneration MEMORY Alzheimer's disease medicinal plants EFFICACY literature review neural regeneration
下载PDF
Role of dietary phytochemicals in modulation of miRNA expression:Natural swords combating breast cancer 被引量:3
3
作者 Banzeer Ahsan Abbasi Javed Iqbal +5 位作者 Tariq Mahmood Ali Talha Khalil Barkat Ali Sobia Kanwal Sayed Afzal Shah Riaz Ahmad 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2018年第9期501-509,共9页
The National Cancer Institute had projected breast cancer(BC) as one of the topmost prevalent malignancies around the globe.In many cases,BC becomes resistant to chemotherapy,radiation and hormonal therapies.Tradition... The National Cancer Institute had projected breast cancer(BC) as one of the topmost prevalent malignancies around the globe.In many cases,BC becomes resistant to chemotherapy,radiation and hormonal therapies.Traditional BC therapies are associated with adverse side effects,drug resistance and recurrence.Extensive research work has shown that these dietary phytochemicals(DPs) may exert therapeutic effects by regulating the miRNA expression.A large number of DPs have been researched as miRNA regulatory agents against BC and some other DPs have not yet been tested against BC.We have discussed the effects of curcumin,diallyl disulphide,3,3′ diindolylmethane,ellagic acid,genistein,indole-3-carbinol,quercetin,resveratrol,and sulforaphane on regulation of expression of BC miRNAs in a wide range of in vitro and in vivo models.We have also shown some of the possible DPs(Oleanolic acid,capsaicin,benzyl isothiocyanate,epigallocatechin gallate,phenethyl isothiocyanate and ursolic acid) that have shown miRNA regulatory activities and have not yet been tested against BC miRNAs.Finally,current limitations,challenges,future perspectives of DPs and BC research are also critically discussed. 展开更多
关键词 BREAST cancer miRNAs DIETARY PHYTOCHEMICALS In VITRO In VIVO
下载PDF
Dietary isoflavones,the modulator of breast carcinogenesis:Current landscape and future perspectives
4
作者 Javed Iqbal Banzeer Ahsan Abbasi +5 位作者 Ali Talha Khalil Barkat Ali Tariq Mahmood Sobia Kanwal Sayed Afzal Shah Wajid Ali 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2018年第3期186-193,共8页
Breast cancer is a frightful disease and serious concern in women around the world causing significant health care burden in both developed and developing countries. Extensive research work has shown that breast cance... Breast cancer is a frightful disease and serious concern in women around the world causing significant health care burden in both developed and developing countries. Extensive research work has shown that breast cancer provides strong resistance to chemical agents, U V radiation,and hormonal treatments. It is generally accepted that cell genetics is not the only main reason for breast cancer and genetic risk factors, for example, mutations in RRCAI and BRCA2 genes constitute 5%-10% of all breast cancer rates. Other related factors include age, gender,race, ethnicity, weight, reproductive factors, exo-and endogenous hormonal exposures, oral contraceptives use, ultraviolet radiation, diet, and night work(circadian disruption). Many studies have revealed that dietary isoflavones regulate breast cancer occurrence, recurrence and prognosis. Dietary isoflavones have long been part of Asian population diet and there is a significant increase as compared to dietary isoflavones intake among other populations. Dietary isoflavones are natural phytoestrogens having both estrogenic and anti-estrogenic potentials on breast cancer cells in culture, animal models and in experimental trials. This literature survey provides a comprehensive overview on the tumor preventive and tumor promoting potentials of dietary isoflavones on breast cancer. In addition, this paper provides a literature review of dietary isoflavones and their effects on up-regulation and down-regulation of different signaling pathways, genes and proteins. Finally, future perspectives of dietary isoflavones and breast cancer researchers are also critically discussed, which will provide a deeper insight regarding the inner molecular mechanisms of action. 展开更多
关键词 Dietary isoflavones Breast cancer Signaling pathways Natural phytoestrogens
下载PDF
Plant-derived anticancer agents: A green anticancer approach 被引量:10
5
作者 Javed Iqbal Banzeer Ahsan Abbasi +4 位作者 Tariq Mahmood Sobia Kanwal Barkat Ali Sayed Afzal Shah Ali Talha Khalil 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2017年第12期1129-1150,共22页
Cancer is a frightful disease and represents one of the biggest health-care issues for the human race and demands a proactive strategy for cure. Plants are reservoirs for novel chemical entities and provide a promisin... Cancer is a frightful disease and represents one of the biggest health-care issues for the human race and demands a proactive strategy for cure. Plants are reservoirs for novel chemical entities and provide a promising line for research on cancer. Hitherto, being effective, chemotherapy is accompanied by certain unbearable side effects. Nevertheless,plants and plant derived products is a revolutionizing field as these are Simple, safer, ecofriendly, low-cost, fast, and less toxic as compared with conventional treatment methods.Phytochemicals are selective in their functions and acts specifically on tumor cells without affecting normal cells. Carcinogenesis is complex phenomena that involves many signaling cascades. Phytochemicals are considered suitable candidates for anticancer drug development due to their pleiotropic actions on target events with multiple manners. The research is in progress for developing potential candidates(those can block or slow down the growth of cancer cells without any side effects) from these phytochemicals. Many phytochemicals and their derived analogs have been identified as potential candidates for anticancer therapy. Effort has been made through this comprehensive review to highlight the recent developments and milestones achieved in cancer therapies using phytomolecules with their mechanism of action on nuclear and cellular factors. Furthermore, drugs for cancer treatment and their limitations have also been discussed. 展开更多
关键词 Cancer Limitations of anticancer drugs PHYTOCHEMICALS ANALOGS
下载PDF
COVID-19 in Nigeria: Why continuous spike in cases?
6
作者 Olutosin Ademola Otekunrin Folorunso Oludayo Fasina +2 位作者 Abiodun Olusola Omotayo Oluwaseun AramideOtekunrin Muhammad Akram 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2021年第1期1-4,共4页
1.COVID-19 in Africa The global emergence of the novel coronavirus disease(COVID-19)in December,2019 became a major turning point in the global health system.As at 4th May,2020,the Republic of South Africa,Egypt and N... 1.COVID-19 in Africa The global emergence of the novel coronavirus disease(COVID-19)in December,2019 became a major turning point in the global health system.As at 4th May,2020,the Republic of South Africa,Egypt and Nigeria had 6783,6465 and 2558 confirmed cases of COVID-19,respectively[1].Surprisingly,the number of cases in South Africa has risen to 563598 cases with 10621 deaths,and the number of cases in Egypt has increased to 95666 cases with 5035 deaths while Nigeria has 46867 cases with 950 deaths[2]. 展开更多
关键词 CASES NIGERIA TURNING
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部